Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Operating Expenses | 17,981 | 16,963 | 19,992 | 37,784 | 27,247 |
| Operating Income | -17,981 | -16,963 | -19,992 | -37,784 | -27,247 |
| Other Income | 899 | 117 | 3,525 | 2,385 | 9,106 |
| Pre-tax Income | -17,082 | -16,846 | -16,467 | -35,399 | -18,141 |
| Net Income Continuous | -17,082 | -16,846 | -16,467 | -35,399 | -18,141 |
| Net Income | $-17,082 | $-16,846 | $-16,467 | $-35,399 | $-18,141 |
| EPS Basic Total Ops | -800.00 | -800.00 | -800.00 | -2,400.00 | -1,600.00 |
| EPS Basic Continuous Ops | -432.58 | -736.04 | -855.25 | -2,270.46 | -1,232.30 |
| EPS Diluted Total Ops | -800.00 | -800.00 | -800.00 | -2,400.00 | -1,600.00 |
| EPS Diluted Continuous Ops | -432.58 | -736.04 | -855.25 | -2,270.46 | -1,232.30 |
| EPS Diluted Before Non-Recurring Items | -432.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-17,972 | $-16,944 | $-19,956 | $-37,742 | $-27,207 |